Acquisition History / Blackstone (BXJB2 Holding) / IROM Group Co., Ltd.
Blackstone (BXJB2 Holding) Acquires IROM Group Co., Ltd.
Announced February 3, 2025 — $167.8M
What happened
IROM Group, a Tokyo Prime-listed clinical trial support and medical services company, announced a management buyout on 3 February 2025 backed by Blackstone through the vehicle B.X.J.B.2 Holding. The tender offer completed on 5 March 2025, taking the company private for JPY 25.042bn.
- Acquirer
- Blackstone (BXJB2 Holding)
- Target
- IROM Group Co., Ltd.
- Announced
- February 3, 2025
- Price
- $167.8M
- Industry
- Clinical trial support and regenerative medicine
- Buyer type
- Private equity
- Fund vehicle
- BXJB2 Holding
- Backing investors
- Blackstone
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Blackstone (BXJB2 Holding) acquire IROM Group Co., Ltd.?
Blackstone (BXJB2 Holding) acquired IROM Group Co., Ltd. on February 3, 2025. This was Blackstone (BXJB2 Holding)'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Blackstone (BXJB2 Holding) pay for IROM Group Co., Ltd.?
Blackstone (BXJB2 Holding) paid $167.8M for IROM Group Co., Ltd..
What does IROM Group Co., Ltd. do?
IROM Group, a Tokyo Prime-listed clinical trial support and medical services company, announced a management buyout on 3 February 2025 backed by Blackstone through the vehicle B.X.J.B.2 Holding. The tender offer completed on 5 March 2025, taking the company private for JPY 25.042bn.
What other Clinical trial support and regenerative medicine companies has Blackstone (BXJB2 Holding) acquired?
IROM Group Co., Ltd. is Blackstone (BXJB2 Holding)'s only publicly tracked acquisition in Clinical trial support and regenerative medicine so far.